Hironobu Toda Selected Research

Diuretics

1/2022

Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hironobu Toda Research Topics

Disease

4	Pathologic Constriction (Stenosis) 04/2023 - 01/2021
4	Heart Failure 01/2022 - 02/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2013
2	Non-alcoholic Fatty Liver Disease 05/2024 - 01/2021
2	Acute Coronary Syndrome 05/2024 - 01/2022
2	Inflammation (Inflammations) 04/2023 - 01/2022
2	Stroke (Strokes) 01/2023 - 01/2013
2	Myocardial Infarction 01/2023 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Diabetes Mellitus 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 11/2021 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2013
1	Ischemia 08/2023
1	Peripheral Arterial Disease 01/2023
1	Glycosuria 01/2022
1	Death (Near-Death Experience) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Atrial Fibrillation 11/2021
1	Hypotension (Low Blood Pressure) 11/2021
1	Proteinuria 01/2019
1	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019
1	Angina Pectoris 01/2016
1	Thrombosis (Thrombus) 01/2013
1	Hemorrhage 01/2013

Drug/Important Bio-Agent (IBA)

3	omega-Chloroacetophenone (Mace)IBA 05/2024 - 01/2013
3	CalciumIBA 04/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2019
3	Phenobarbital (Luminal)FDA Link 12/2022 - 01/2021
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2022 - 01/2020
3	voglibose (Basen)IBA 01/2022 - 01/2020
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2020
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2020
2	Bisoprolol (Concor)FDA LinkGeneric 11/2021 - 01/2020
1	LipidsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	DiureticsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Glycoside Hydrolase InhibitorsIBA 01/2022
1	SodiumIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	SymportersIBA 01/2022
1	AdiponectinIBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Tolvaptan FDA Link 02/2016
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 02/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2013
1	zotarolimusIBA 01/2013

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2013
1	Catheters 08/2023
1	Surgical Amputation (Amputations) 01/2023
1	Exercise Therapy (Therapy, Exercise) 01/2023
1	Stents 01/2013
1	Percutaneous Coronary Intervention 01/2013